Expectation optimization: A short (2-5 min) verbal intervention will be createad individually based on the expectation of the patient towards the procedure.
Study summary
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* symptomatic atrial fibrillation
* indication for pulmonary vein isolation
* sufficient command of the German language
Exclusion Criteria:
* age \<18 years
* permanent atrial fibrillation
* presence of psychiatric disorders which impair the study participitatin
* presence of another medical condiction which influences quality of life stronger than the cardiac condition
* atrial fibrillation induced by intoxication, medicamentation or infection
* inability to grap the course of the study
Primary outcome measure(s)
Quality of life (questionaire) — 3 months Quality of life of life will be compared between groups and between different time points (before versus 3 months after ablation) with "the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire". An overall AFEQT score ranges from 0 to 100. A score of 0 corresponds to complete disability (or responding "extremely" limited, difficult or bothersome to all questions answered), while a score of 100 corresponds to no disability (or responding "not at all" limited, difficult or bothersome to all questions answered). Therefore, a positive change in score corresponds to improvement in AF symptoms.
Trial sites (2)
Facility
City
Region
Status
Evangelic Hospital Düsseldorf
Düsseldorf
North Rhine-Westfalia
Recruiting
Westdeutsches Herz- und Gefäßzentrum
Essen
Germany
Recruiting
More Evangelical Hospital Düsseldorf trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.